Eam Global Investors LLC Fulgent Genetics, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$31.01 - $52.1 $947,603 - $1.59 Million	-30,558 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.89 - $50.51 $485,566 - $1.54 Million	30,558 New	30,558 $1.22 Million
Q2 2020 Aug 13, 2020	SELL	$8.89 - $18.28 $1.07 Million - $2.2 Million	-120,232 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$6.75 - $19.75 $23,206 - $67,900	-3,438 Reduced 2.78%	120,232 $1.29 Million
Q4 2019 Feb 10, 2020	BUY	$9.29 - $15.82 $1.15 Million - $1.96 Million	123,670 New	123,670 $1.6 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.